US Patent 10849982 C3-carbon linked glutarimide degronimers for target protein degradation
Patent 10849982 was granted and assigned to C4 Therapeutics on December, 2020 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 10849982 C3-carbon linked glutarimide degronimers for target protein degradation
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.